Abstract
The problem of myomectomy during cesarean section is relevant and disputable. Currently, there are no clear guidelines available for conditions and recommendations for performing this procedure during cesarean deliveries. Many obstetricians are hesitant to expand the scope of surgery due to the potential complications, such as increased intraoperative bleeding, postoperative hematomas, the risk of postoperative sepsis, venous thromboembolism, and abdominal adhesions. Additionally, long-term complications can arise from scarring on the uterus that can affect future fertility. This article presents an analysis of case series of cesarean deliveries with and without myomectomies performed at the Department of Obstetrics and Gynecology at St. Petersburg State Medical University in 2022.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval and accordance statement : protocols for clinical trials were approved by the CLinical Trial Ethics Committee of the Russian State Pediatric University (Approval no. 1456 /2019) on 12.Feb.2019, Chair ass. prof. Krylov Kirill Urjevich
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
